479 filings
Page 2 of 24
CORRESP
PCSA
Processa Pharmaceuticals Inc
22 Jan 24
Correspondence with SEC
12:00am
S-1/A
PCSA
Processa Pharmaceuticals Inc
IPO registration (amended)
22 Jan 24
12:00am
8-K
PCSA
Processa Pharmaceuticals Inc
19 Jan 24
Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
8:00am
8-K
PCSA
Processa Pharmaceuticals Inc
18 Jan 24
Material Modifications to Rights of Security Holders
8:30am
8-K
PCSA
Processa Pharmaceuticals Inc
8 Jan 24
Regulation FD Disclosure
4:30pm
UPLOAD
PCSA
Processa Pharmaceuticals Inc
5 Jan 24
Letter from SEC
12:00am
S-1
PCSA
Processa Pharmaceuticals Inc
IPO registration
29 Dec 23
8:55am
8-K
PCSA
Processa Pharmaceuticals Inc
19 Dec 23
FDA acknowledges that NGC-Cap is a New Chemical Entity given the changes to metabolism and distribution of its major metabolite 5-FU
9:00am
8-K
PCSA
Processa Pharmaceuticals Inc
5 Dec 23
Regulation FD Disclosure
5:18pm
4
PCSA
Processa Pharmaceuticals Inc
28 Nov 23
Processa Pharmaceuticals / Justin W Yorke ownership change
4:13pm
8-K
PCSA
Processa Pharmaceuticals Inc
16 Nov 23
Regulation FD Disclosure
3:10pm
8-K
PCSA
Processa Pharmaceuticals Inc
15 Nov 23
Submission of Matters to a Vote of Security Holders
11:30am
10-Q
2023 Q3
PCSA
Processa Pharmaceuticals Inc
Quarterly report
13 Nov 23
4:00pm
8-K
PCSA
Processa Pharmaceuticals Inc
13 Nov 23
Departure of Directors or Certain Officers
2:45pm
4/A
PCSA
Processa Pharmaceuticals Inc
23 Oct 23
Processa Pharmaceuticals / Justin W Yorke ownership change
5:31pm
8-K
PCSA
Processa Pharmaceuticals Inc
16 Oct 23
Regulation FD Disclosure
9:15am
4
Wendy Guy
12 Oct 23
Processa Pharmaceuticals / Wendy Guy ownership change
6:07pm
4
George K Ng
12 Oct 23
Processa Pharmaceuticals / George K Ng ownership change
6:04pm
4
Patrick Lin
12 Oct 23
Processa Pharmaceuticals / Patrick Lin ownership change
6:01pm
4
PCSA
Processa Pharmaceuticals Inc
12 Oct 23
Processa Pharmaceuticals / James H Stanker ownership change
5:58pm